Urinary trehalase activity in chronic glomerulonephritis. 1993

T Niwa, and T Katsuzaki, and T Yazawa, and N Tatemichi, and Y Emoto, and T Miyazaki, and K Maeda
Department of Internal Medicine, Nagoya University Branch Hospital, Japan.

To determine the diagnostic role of urinary trehalase in chronic glomerular disease, urinary trehalase activity and other urinary markers such as N-acetyl-beta-D-glucosaminidase (NAG), alanine aminopeptidase (AAP), alkaline phosphatase (ALP), gamma-glutamyltranspeptidase (gamma-GTP), lactate dehydrogenase (LDH), lysozyme and beta 2-microglobulin (BMG) were measured in patients with chronic glomerulonephritis, nephrotic syndrome and chronic renal failure. Urinary trehalase activity was significantly increased in chronic glomerular disease, especially nephrotic syndrome, as compared with that in the healthy subjects. The highest incidence of elevated excretion was observed for trehalase with 52% in chronic glomerular disease, followed by NAG. Urinary trehalase activities in the patients were significantly correlated with the urinary levels of protein, NAG and AAP and total score of tubular damage, but not correlated with urinary levels of BMG or lysozyme. In patients with chronic glomerulonephritis and nephrotic syndrome, there was no significant difference in urinary trehalase activities between with and without hematuria. These results indicate that in some patients with chronic glomerular disease, there is tubular involvement as substantiated by elevation of the other urinary enzymes and BMG. Urinary trehalase is elevated more often in these types of disease than other markers of tubular damage.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D002240 Carbohydrate Sequence The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS. Carbohydrate Sequences,Sequence, Carbohydrate,Sequences, Carbohydrate
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000118 Acetylglucosaminidase A beta-N-Acetylhexosaminidase that catalyzes the hydrolysis of terminal, non-reducing 2-acetamido-2-deoxy-beta-glucose residues in chitobiose and higher analogs as well as in glycoproteins. Has been used widely in structural studies on bacterial cell walls and in the study of diseases such as MUCOLIPIDOSIS and various inflammatory disorders of muscle and connective tissue. N-Acetyl-beta-D-glucosaminidase,Chitobiase,N,N-Diacetylchitobiase,N-Ac-beta-Glucosaminidase,NAGase,beta-D-Acetamido-2-Deoxyglucosidase,beta-D-N-acetylglucosaminidase,beta-N-Acetylglucosaminidase,N Ac beta Glucosaminidase,N Acetyl beta D glucosaminidase,N,N Diacetylchitobiase,beta D Acetamido 2 Deoxyglucosidase,beta D N acetylglucosaminidase,beta N Acetylglucosaminidase

Related Publications

T Niwa, and T Katsuzaki, and T Yazawa, and N Tatemichi, and Y Emoto, and T Miyazaki, and K Maeda
February 1988, Vrachebnoe delo,
T Niwa, and T Katsuzaki, and T Yazawa, and N Tatemichi, and Y Emoto, and T Miyazaki, and K Maeda
November 1986, Nihon Sanka Fujinka Gakkai zasshi,
T Niwa, and T Katsuzaki, and T Yazawa, and N Tatemichi, and Y Emoto, and T Miyazaki, and K Maeda
January 2005, Journal of nephrology,
T Niwa, and T Katsuzaki, and T Yazawa, and N Tatemichi, and Y Emoto, and T Miyazaki, and K Maeda
January 1979, Terapevticheskii arkhiv,
T Niwa, and T Katsuzaki, and T Yazawa, and N Tatemichi, and Y Emoto, and T Miyazaki, and K Maeda
December 1973, American journal of clinical pathology,
T Niwa, and T Katsuzaki, and T Yazawa, and N Tatemichi, and Y Emoto, and T Miyazaki, and K Maeda
June 1987, Archives of toxicology,
T Niwa, and T Katsuzaki, and T Yazawa, and N Tatemichi, and Y Emoto, and T Miyazaki, and K Maeda
January 1972, International urology and nephrology,
T Niwa, and T Katsuzaki, and T Yazawa, and N Tatemichi, and Y Emoto, and T Miyazaki, and K Maeda
January 2001, Medycyna pracy,
T Niwa, and T Katsuzaki, and T Yazawa, and N Tatemichi, and Y Emoto, and T Miyazaki, and K Maeda
January 2021, Advances in experimental medicine and biology,
T Niwa, and T Katsuzaki, and T Yazawa, and N Tatemichi, and Y Emoto, and T Miyazaki, and K Maeda
May 1970, Medicine,
Copied contents to your clipboard!